Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Annals of Diagnostic Pathology
|
October 2, 2023
Immunohistochemistry and immunofluorescence utilization audit by subspecialty in an academic setting: A step toward stewardship
Mahmoud A Khalifa, Brooke Gagner, Liam Chen, et al.
Molecular Cancer Therapeutics
|
August 31, 2019
<i>COMMD3:BMI1</i> Fusion and COMMD3 Protein Regulate <i>C-MYC</i> Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer
Syed Umbreen, Mudassir Meraj Banday, Anmbreen Jamroze, et al.
The Prostate
|
July 21, 2020
Identifying and treating ROBO1<sup>-ve</sup> /DOCK1<sup>+ve</sup> prostate cancer: An aggressive cancer subtype prevalent in African American patients
Marina G Ferrari, Arsheed A Ganaie, Ashraf Shabenah, et al.
Bioengineering & Translational Medicine
|
January 23, 2026
Vitrification and rapid rewarming of precision-cut liver slices for pharmacological and biomedical research
Srivasupradha Ramesh, Joseph Sushil Rao, Bat-Erdene Namsrai, et al.
Biorxiv : the Preprint Server for Biology
|
December 23, 2024
Vitrification and rapid rewarming of precision-cut liver slices for pharmacological and biomedical research
Srivasupradha Ramesh, Joseph Sushil Rao, Bat-Erdene Namsrai, et al.
Molecular Cancer Therapeutics
|
October 1, 2020
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy <i>S100A4</i> as a Clinical Predictor
Arsheed A Ganaie, Adrian P Mansini, Tabish Hussain, et al.
Urologic Oncology
|
May 26, 2015
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation
Mehrad Adibi, Arun Z Thomas, Leonardo D Borregales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2018
<i>BMI1</i> Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models
Arsheed A Ganaie, Firdous H Beigh, Matteo Astone, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome
Paari Murugan, Liwei Jia, Renzo G Dinatale, et al.
NPJ Precision Oncology
|
September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases
Megan L Ludwig, David Moline, Alec Horrmann, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Annals of Diagnostic Pathology
|
October 2, 2023
Immunohistochemistry and immunofluorescence utilization audit by subspecialty in an academic setting: A step toward stewardship
Mahmoud A Khalifa, Brooke Gagner, Liam Chen, et al.
Molecular Cancer Therapeutics
|
August 31, 2019
<i>COMMD3:BMI1</i> Fusion and COMMD3 Protein Regulate <i>C-MYC</i> Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer
Syed Umbreen, Mudassir Meraj Banday, Anmbreen Jamroze, et al.
The Prostate
|
July 21, 2020
Identifying and treating ROBO1<sup>-ve</sup> /DOCK1<sup>+ve</sup> prostate cancer: An aggressive cancer subtype prevalent in African American patients
Marina G Ferrari, Arsheed A Ganaie, Ashraf Shabenah, et al.
Bioengineering & Translational Medicine
|
January 23, 2026
Vitrification and rapid rewarming of precision-cut liver slices for pharmacological and biomedical research
Srivasupradha Ramesh, Joseph Sushil Rao, Bat-Erdene Namsrai, et al.
Biorxiv : the Preprint Server for Biology
|
December 23, 2024
Vitrification and rapid rewarming of precision-cut liver slices for pharmacological and biomedical research
Srivasupradha Ramesh, Joseph Sushil Rao, Bat-Erdene Namsrai, et al.
Molecular Cancer Therapeutics
|
October 1, 2020
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy <i>S100A4</i> as a Clinical Predictor
Arsheed A Ganaie, Adrian P Mansini, Tabish Hussain, et al.
Urologic Oncology
|
May 26, 2015
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation
Mehrad Adibi, Arun Z Thomas, Leonardo D Borregales, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2018
<i>BMI1</i> Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models
Arsheed A Ganaie, Firdous H Beigh, Matteo Astone, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 24, 2021
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome
Paari Murugan, Liwei Jia, Renzo G Dinatale, et al.
NPJ Precision Oncology
|
September 30, 2024
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases
Megan L Ludwig, David Moline, Alec Horrmann, et al.
Page
of 9